Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
Open | $0.17 |
Close | $0.16 |
Volume / Avg. | 680.58K / 3.93M |
Day Range | $0.16 - $0.17 |
52 Wk Range | 0.08 - 4.59 |
Market Cap | $8.94M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 2.15% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kintara Therapeutics (NASDAQ:KTRA) through any online brokerage.
Other companies in Kintara Therapeutics’s space includes: Addex Therapeutics (NASDAQ:ADXN), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), GlycoMimetics (NASDAQ:GLYC) and Portage Biotech (NASDAQ:PRTG).
Kintara Therapeutics has a consensus price target of $7.33.
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $0.1615 last updated September 23, 2024 at 7:41 PM EDT.
There are no upcoming dividends for Kintara Therapeutics.
Kintara Therapeutics’s Q1 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Kintara Therapeutics.
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.